InvestorsHub Logo

scottsmith

02/18/17 4:09 PM

#172557 RE: groton68 #172552

Might be some there there to that reasoning.

On the other hand, BPs take on risk in large and long trials regularly. Plus, as I understand it, absssi was greatly de-risked after the 2b to the point where some have called it a lock.

frrol

02/18/17 4:40 PM

#172558 RE: groton68 #172552

I think, more accurately: there are many in development, but few that are very far along, and fewer that are truly novel and with long term promise.

cabel

02/18/17 4:44 PM

#172559 RE: groton68 #172552

I was told that BP will purchase a Psoriasis drug after a good Phase 2,... while with antibiotics,.. more likely during or after Phase 3.